Clearance Summary
CARDIOLIPIN AUTOANTIBODY IMMUNOLOGICAL TEST SYSTEM received FDA 510(k) clearance under submission number K091845, sponsored by Phadia US, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 2010-06-07.
- Submission: K091845
- Applicant / Sponsor: Phadia US, Inc.
- Clearance pathway: Traditional
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5660
- Decision date: 2010-06-07
Classification & Regulation
This clearance is catalogued under FDA product code MID and 21 CFR 866.5660, within the Immunology review panel as a Class II device.